REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmamax SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pharmamax SIA Profile Updated: May 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Pharmamax SIA is a company in Latvia, with a head office in Riga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Pharmamax SIA was incorporated on March 11, 2015. Pharmamax SIA currently employs 8 (2021) people. The company’s latest financial report indicates a net sales revenue drop of 8.65% in 2025. Its’ total assets recorded a growth of 79.14%. Pharmamax SIA’s net profit margin decreased by 1.14% in 2025.

Headquarters
Delu iela 4
Riga; Riga; Postal Code: 1004

Contact Details: Purchase the Pharmamax SIA report to view the information.

Basic Information
Total Employees:
Purchase the Pharmamax SIA report to view the information.
Registered Capital:
Purchase the Pharmamax SIA report to view the information.
Financial Auditors:
Purchase the Pharmamax SIA report to view the information.
Incorporation Date:
March 11, 2015
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
52.38%
Purchase this report to view the information.
4.76%
Company Performance
Financial values in the chart are available after Pharmamax SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-8.65%
Total Operating Revenue
-8.34%
Operating Profit
21.08%
Net Profit/Loss for the Period
-97.67%
Total Assets
79.14%
Total Equity
-88.06%
Operating Profit Margin
2.28%
Net Profit Margin
-1.14%
Return on Equity (ROE)
-61.12%
Quick Ratio
-0.06%
Cash Ratio
-0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?